# The Protective Effect of Phenolic Acids on Liver Disease: A Review of Possible Mechanisms

**Authors:** Xinyi Ma, Suhui Xiong, Feng Xiang, Yamei Li, Yan Lin, Yuexin Liu, Limei Lin, Jingchen Xie

PMC · DOI: 10.3390/antiox14101247 · Antioxidants · 2025-10-17

## TL;DR

This review explores how phenolic acids may protect the liver from various diseases through mechanisms like reducing inflammation and regulating metabolism.

## Contribution

The paper systematically reviews the mechanisms by which phenolic acids protect against multiple liver diseases.

## Key findings

- Phenolic acids show protective effects against drug-induced liver injury, alcoholic liver disease, and liver fibrosis.
- Their benefits include anti-inflammatory, antioxidant, and lipid-regulating properties.
- Phenolic acids also modulate gut microbiota and inhibit cell apoptosis in liver diseases.

## Abstract

(1) Background: This article reviews the biological characteristics of phenolic acid compounds, focusing on their mechanisms of action in various liver diseases. (2) Methods: The review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We utilized PubMed and Web of Science databases to search for relevant studies on the use of phenolic acids in liver diseases from 2015 to 2025. (3) Results: Phenolic acids can improve different types of liver diseases, including drug-induced liver injury (DILI), alcoholic liver disease (ALD), metabolic dysfunction-associated steatotic liver disease, liver fibrosis, and liver cancer. Their beneficial effects are attributed to mechanisms such as anti-inflammatory properties, antioxidant activity, regulation of lipid metabolism, inhibition of cell apoptosis, and modulation of gut microbiota. (4) Conclusion: Phenolic acids exhibit a good protective effect against various liver diseases and are associated with multiple signaling pathways. However, the primary target cells and specific molecular targets of phenolic acids remain unclear, necessitating further research to elucidate their protective mechanisms in liver diseases.

## Linked entities

- **Diseases:** drug-induced liver injury (MONDO:0005359), alcoholic liver disease (MONDO:0043693), metabolic dysfunction-associated steatotic liver disease (MONDO:0013209), liver cancer (MONDO:0002691)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), ALD (MESH:D008108), liver cancer (MESH:D006528), DILI (MESH:D056486), metabolic dysfunction (MESH:D008659), Liver Disease (MESH:D008107), liver fibrosis (MESH:D008103)
- **Chemicals:** lipid (MESH:D008055), Phenolic Acids (MESH:C017616)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12562122/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12562122/full.md

## References

214 references — full list in the complete paper: https://tomesphere.com/paper/PMC12562122/full.md

---
Source: https://tomesphere.com/paper/PMC12562122